Daewoong Pharmaceutical Co (XKRX:069620) Cash From Other Investing Activities : ₩-490 Mil (TTM As of Sep. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Daewoong Pharmaceutical Co Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Daewoong Pharmaceutical Co's cash from other investing activities for the three months ended in Sep. 2024 was ₩0 Mil. It means Daewoong Pharmaceutical Co received ₩0 Mil from other investing activities. Daewoong Pharmaceutical Co's cash from other investing activities for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-490 Mil.

Daewoong Pharmaceutical Co Cash From Other Investing Activities Historical Data

The historical data trend for Daewoong Pharmaceutical Co's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daewoong Pharmaceutical Co Cash From Other Investing Activities Chart

Daewoong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash From Other Investing Activities

Get a 7-Day Free Trial

17,570.00

-2,351.05

-10.46

Daewoong Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash From Other Investing Activities	Get a 7-Day Free Trial															7,899.28	-489.78	-	-	-

Daewoong Pharmaceutical Co Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-490 Mil.

Daewoong Pharmaceutical Co Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Daewoong Pharmaceutical Co's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Daewoong Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewoong Pharmaceutical Co Ltd (XKRX:069620) » Definitions » Cash From Other Investing Activities

Traded in Other Exchanges

N/A

Address

12, Bongeunsa-ro 114-gil, Daewoong Pharmaceutical Building, Gangnam-gu, Seoul, KOR

Website

https://www.daewoong.co.kr

Daewoong Pharmaceutical Co Ltd develops, manufactures and sells prescription drug products. The company's product portfolio comprises products such as Moxicle, Plunazol Cap, Bearcef tab, Newdizime etc. It develops and promotes brands such as Ursa, Nabota, Luphere, Easyef, Cretropin. The company has manufacturing facilities at Hyangnam and Sungnam.

Daewoong Pharmaceutical Co Headlines

No Headlines